Loading...
Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae
BACKGROUND: Tigecycline is regarded as a last resort treatment for carbapenem-resistant Enterobacter cloacae (CREC) infections, and increasing numbers of tigecycline- and carbapenem-resistant E. cloacae (TCREC) isolates have been reported in recent years. However, risk factors and clinical impacts o...
Na minha lista:
| Udgivet i: | Infect Drug Resist |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430992/ https://ncbi.nlm.nih.gov/pubmed/30936728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S189941 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|